Medscape is available in 5 Language Editions – Choose your Edition here.


Adhesive Capsulitis in Physical Medicine and Rehabilitation Treatment & Management

  • Author: André Roy, MD, FRCPC; Chief Editor: Stephen Kishner, MD, MHA  more...
Updated: Apr 26, 2016

Rehabilitation Program

Physical Therapy

Although studies have shown the efficacy of physical therapy, no current evidence has suggested that physical therapy alone improves function in the treatment of FS.[15, 16, 17, 18] However, physical therapy associated with an intra-articular injection of corticosteroid improves function and ROM more rapidly than does intra-articular corticosteroid injection alone.[15, 19]

Therapeutic exercises

Although many therapeutic exercises are described, few have been evaluated in the treatment of FS. Therapeutic exercises that have been studied include articular stretching and pulley therapy.[20, 21, 22] Passive articular stretching exercises improve ROM. The superiority of supervised versus home exercise programs has yet to be demonstrated.[23]

In an assessment of nonsurgical management of 75 patients with FS, Russell and colleagues found that individuals who participated in a hospital-based group exercise class achieved greater improvement in shoulder symptoms than did individuals who participated in individual physical therapy or in home exercises alone. It was also found that patients in the group exercise and individual physical therapy programs showed greater improvement in range of motion and in their Hospital Anxiety and Disability Scale (HADS) anxiety scores than did the home-exercise patients.[24]

Manual therapy

Data from 2 studies support the use of manual therapy to improve ROM in the short term. One study showed that passive mobilization in the end-range position of the glenohumeral joint was more effective for improving ROM and function than was passive mobilization in the pain-free zone.[25] However, the overall difference between the interventions was small. In addition, patients appeared to achieve greatest improvement in ROM when treatment was administered early.[26]

In summary, the findings indicated that patients with FS improve with physical therapy regardless of when it is administered after the onset of FS but that they achieve the greatest improvement in their ROM when treatment is administered early.

Physical modalities

Many electroanalgesic and thermoanalgesic modalities are often used in physical therapy. Prospective, randomized, placebo-controlled clinical trials have demonstrated the inefficacy of bipolar interferential electrotherapy, TENS (transcutaneous electrical nerve stimulation) pulsed ultrasound therapy, laser therapy, and magnetotherapy with electromagnetic fields in the treatment of painful shoulder disorders. Indeed, a systematic review of randomized clinical trials has demonstrated that little evidence supports the use of common physiotherapeutic modalities to treat shoulder pain. (Nonetheless, clinical observations suggest that electroanalgesia and heat can provide some temporary relief to patients with severe shoulder pain and that they can do so without side effects.)

In summary, physical therapy alone has not been shown to improve function. However, when associated with an intra-articular corticosteroid injection, physical therapy improves ROM and function more rapidly than does intra-articular corticosteroid injection alone. A study by Klç et al indicated that in patients with FS, combining physical therapy with a suprascapular nerve block leads to greater improvements in pain and functional status than does physical therapy alone.[27] The effectiveness of physical modalities has not been demonstrated. However, therapeutic exercises and manual therapy do improve ROM (see above).

Given the paucity of evidence supporting the effectiveness of physical therapy, the present authors believe that clinicians should be most conservative in designing a physical therapy program for patients with FS. An intermittently supervised, home-based articular stretching and strength-maintenance program can be combined with manual therapy, the appropriate analgesic medications, and the judicious use of electroanalgesia and warm packs. This approach generally suffices to provide adequate pain relief in most patients while the disease runs its usual, favorable course. (For additional information, see Home Exercises for the Stiff Shoulder, on the University of Washington School of Medicine Web site.

Occupational Therapy

Patients with severe FS may benefit from a referral to an occupational therapist for assistance and instruction in performing activities of daily living (ADLs). The occupational therapist helps the patient learn how to use adaptive equipment and suggest home and workplace modifications that may be necessary and beneficial for completing professional activities and routine daily tasks (eg, dressing, bathing, grooming). (See also Patient Education.) However, the effectiveness of these interventions has yet to be demonstrated. Researchers who performed a systematic review concluded that evidence supporting the effectiveness of rehabilitation in the workplace is lacking.[28]


Medical Issues/Complications

Certain authors, including the present authors, believe that idiopathic FS should be considered a distinct clinical entity. The prognosis and therapeutic approach for idiopathic FS differ from those of posttraumatic shoulder stiffening resulting from a fracture or a surgical insult to the glenohumeral joint.


Surgical Intervention

Duplay, the first person to describe the syndrome of FS, in 1872, proposed treating this condition with manipulation of the glenohumeral joint, with the patient under general anesthesia. Although some orthopedic surgeons continue to practice this technique, the benefits of this approach have not been demonstrated in controlled clinical trials.

In 1972, Hazelman noted that, in the context of a prospective controlled clinical trial, patients who had been treated with manipulation of the glenohumeral joint fared no better than did patients who received only a series of steroid injections and physical therapy.[29] Data from a long-term prospective study by Binder and colleagues seemed to support the notion that subjects who are treated with vigorous shoulder manipulation fare worse than do those who are not treated at all.[8]

A 2009 study by Jacobs et al also found no evidence that manipulation provides a better treatment outcome in FS.[30] The investigators divided 53 patients suffering from idiopathic FS into 2 groups, with one undergoing shoulder manipulation under anesthetic and the other being treated with intra-articular steroid injections and distention (see Other Treatment). After 2 years of follow-up, the investigators found no statistical difference between outcome measures in the 2 groups.

Various improvements in surgical techniques, such as the advent of controlled capsular release by using arthroscopic access to the anterior glenohumeral joint capsule and the coracohumeral ligament, appear to offer promising treatments. However, the effectiveness of these surgical techniques has yet to be demonstrated in controlled clinical trials.

Considering the favorable prognosis for patients with idiopathic FS, surgical intervention should probably be reserved for rare patients whose condition does not respond to maximal conservative modalities implemented over a sufficient period of time.[31]

Some authors propose early surgical intervention in patients with FS because of the patients' high risk of permanent contracture of the glenohumeral joint. However, this approach remains controversial because patients with diabetes often have recurring pain and contracture in the postoperative rehabilitation phase and because their rate of preoperative complications is generally increased.


Other Treatment

Studies of intra-articular and intrabursal injections, glenohumeral distention arthrography, and nerve blocks have been conducted, as described in the following text.

Intra-articular and intrabursal injections

Intra-articular corticosteroid injections

Intra-articular injections of steroid derivatives are the second most common medical intervention for treating painful joint conditions. (The most common intervention is the administration of nonsteroidal anti-inflammatory drugs [NSAIDs]).

A blinded, randomized, controlled study by Yoon and colleagues indicated that high- and low-dose intra-articular corticosteroid injections for FS are equally effective. The study involved 53 patients with primary adhesive capsulitis in the freezing stage. Twenty patients received a single ultrasonographically guided intra-articular injection of 40 mg of triamcinolone acetonide, while another 20 received an ultrasonographically guided intra-articular injection of 20 mg of the drug and 13 received a placebo. The injections were followed by participation in a home exercise program, with posttreatment follow-up at 1, 3, 6, and 12 weeks. The investigators found that there was greater improvement in shoulder pain and passive range of motion in the high- and low-dose groups than in the placebo patients but also that the level of improvement was about the same in both corticosteroid groups.[32]

The rationale for injection of an intra-articular steroid derivative is to allow direct delivery of a modest dose of concentrated drug with analgesic and anti-inflammatory properties to the targeted site of pathology.[33] Researchers at the Manchester Rheumatology Service investigated the accuracy of a variety of joint injections that were administered by using anatomic landmarks to the upper and lower extremities. Their study demonstrated inaccurate placement of the drug in 65% of 108 joints injected.

A study by Eustace and colleagues showed results similar to those above, demonstrating that 68% of shoulder injections performed by expert specialist physicians without radiologic guidance failed to hit their target.[34] Overall, when radiologic guidance is not used, the accuracy of these injections is poor. When anatomic landmarks are used, the rate of misplacement is as high as 58% in the glenohumeral joint and as high as 69% in the subacromiodeltoidian bursae. Accuracy of the injection is associated with improved clinical results.[34, 35, 36]

If the rationale for using an intra-articular injection of steroid derivative is to deliver targeted therapy, the target in FS is the glenohumeral joint. The work by Eustace and coauthors suggests that targeted therapy that does not hit its target is not ineffective.[34] In general, however, physicians who are less experienced in joint injection than the expert rheumatologists in that study should avoid injecting shoulders without radiologic guidance. The results of their study are impressive, even for physicians who are experienced in the field of joint injections.

Eustace's study also puts an interesting twist on the interpretation of data from placebo-controlled clinical trials that failed to demonstrate favorable results with the steroid injection into the shoulder to treat FS. Some investigators did use radiologic guidance, but most employed anatomic landmarks.[15, 37, 38, 39, 40] Because some studies involved radiologic confirmation of location of the injectate, most of the injections may have missed their target. The present authors believe that no conclusions can be drawn from studies using anatomic landmarks, given the inaccuracy of the intervention.

On the other hand, a study by Ranalletta et al found that in patients with FS, a single intra-articular corticosteroid injection performed without imaging control, prior to the start of a physical therapy program, produced faster pain relief and quicker improvement in shoulder function and motion than did treatment with oral nonsteroidal anti-inflammatory drugs (NSAIDs) and physical therapy. The study found that patients in the corticosteroid group experienced faster improvements in pain, function, and motion during the first 8 weeks posttreatment than did the NSAID group. However, by final follow-up, at 12 weeks, there was no significant difference between the two groups regarding these factors.[41]

From the current literature, we know that intra-articular corticosteroid injections or distention arthrography with corticosteroids or sodium chloride solution (discussed below) considerably improve FS in the short term. However, in the long term, they are not superior to placebo but they are superior to supervised physical therapy.[15, 42] Whether their effectiveness is the result of distention arthrography, the intra-articular corticosteroid, or their combination is unclear because most studies used corticosteroids.

Intrabursal corticosteroid injections

Many authors have shown that the pathology of FS is in the extra-articular structures, such as the coracohumeral ligament, the interval of the rotator cuff, the subacromial space, and the articular capsule.[43, 44, 45] From a pathophysiologic point of view, a rationale supports the use of corticosteroid injection in the subacromiodeltoidian bursa to treat FS.

A comparison of intra-articular and intrabursal injections with lidocaine alone or with lidocaine and a corticosteroid showed similar decreases in pain and increases in ROM in all groups.[22] However, a significant short-term decrease in pain was observed in the lidocaine-plus-corticosteroid group compared with the lidocaine-only group. Data from another study supported these findings, showing that patients whose condition did not improve with distention arthrography benefited from an intra-articular bursal injection of corticosteroid.[46]

Because of the inaccuracy of injections given by using anatomic landmarks, the present authors recommend that intra-articular and intrabursal injections should be administered by using fluoroscopic guidance. When the needle is accurately positioned, intra-articular corticosteroid injection and distention arthrography are effective in the short them. However, in the long term, they are not superior to placebo. This observation is not surprising given the favorable evolution of this disease. An intrabursal injection of corticosteroid can be used as a complementary treatment to intra-articular injection and distention arthrography or as treatment in patients whose condition does not improve with an intra-articular corticosteroid injection or with distention arthrography.

Many issues remain unclear. Factors to be resolved are whether distention is necessary, whether an intra-articular corticosteroid injection without distention (or vice versa) is enough, how many injections are needed, the stage of disease at which injections should be administered, the most effective corticosteroid, and the most effective dosage.

Intra-articular injection of sodium hyaluronate

Sodium hyaluronate has a metabolic effect on the articular cartilage, synovial tissues, and liquid. Few studies on the effect of sodium hyaluronate have been reported.[47, 48, 49, 50] In one controlled study, sodium hyaluronate was as effective as an intra-articular corticosteroid injection or physical therapy in improving function, but it was less effective than the comparators in improving ROM.[47] In another randomized controlled trial involving 70 patients with FS, the addition of intra-articular hyaluronate injections to physical therapy produced no added benefit[50] . Although additional studies are needed before conclusions about efficacy can be drawn, intra-articular injections of sodium hyaluronate may be an alternative treatment for FS, mainly in patients in whom corticosteroid injections are contraindicated.

Glenohumeral distention arthrography

One controlled study showed no benefit to distention arthrography over intra-articular corticosteroid injection without distention.[51] Another controlled study showed a significant increase in ROM and a significant decrease in the use of analgesics after distention arthrography, compared with the use of intra-articular corticosteroid injection alone.[52]

The benefit of performing distention arthrography until the capsule ruptures must be demonstrated.[22, 53]

One uncontrolled study that was designed to examine the optimal number of distention arthrography procedures that should be performed showed that 2 procedures administered within 3 weeks, when combined with home exercises, significantly improved function. However, a third procedure offered no benefit.[54]

Another unknown factor is the stage at which infiltration should be performed. To the authors' knowledge, only 1 uncontrolled study on this question has been completed.[38] The researchers concluded that distention arthrography should be done in the second stage of disease that is not progressing, despite the patient's participation in physical therapy.

Nerve blocks

Suprascapular nerve block

The suprascapular nerve block is a simple procedure but is not well known by most clinicians.

Dangoisse's technique for suprascapular nerve block was modified to render it steroid free and accessible to most physicians who practice musculoskeletal medicine in ambulatory-care facilities and private offices. A 3.75-cm, 25-gauge needle is directed in the plane of the scapula toward the center of the floor of the supraspinous fossa. The needle-insertion point is 2 cm above the bisection point of the upper border of the spine of the scapula. After aspiration is performed to rule out intravascular needle placement, 10 mL of bupivacaine 0.5 is slowly injected into the floor of the supraspinous fossa to fill the fascial contents of this fossa and to produce an indirect suprascapular nerve block. The highly concentrated bupivacaine bathes the suprascapular nerve as it enters the fossa through the suprascapular notch.

Since 1996, thousands of bupivacaine suprascapular nerve blocks have been performed by using the above-described technique. No notable complications, other than vasovagal episodes and tenderness at the site of injection, have occurred. Most specialists in musculoskeletal medicine who treat shoulder pain in an outpatient context can safely and inexpensively perform modified indirect suprascapular nerve blocks without radiologic guidance if they are adequately trained.

A randomized controlled trial was performed to compare the effectiveness of a single suprascapular nerve block with that of series of intra-articular corticosteroid injections given by using anatomic landmarks without fluoroscopic guidance.[55] Pain decreased and ROM increased more rapidly and more completely with the nerve block than they did with the intra-articular injections.

A double-blind, placebo-controlled, randomized trial showed the superiority of 3 bupivacaine suprascapular nerve blocks.[56] At 1 month, a 64% decrease in pain was reported in the bupivacaine group compared with 13% in the placebo group. Although functional improvement was superior with bupivacaine, the difference was not statistically significant. The same authors preformed a double-blind, placebo-controlled, randomized trial larger than the previous study by using the same protocol (unpublished data). They observed no statistically significant difference between bupivacaine and placebo in terms of pain and function.

Some studies have shown the effectiveness of bupivacaine suprascapular nerve blocks to treat chronic tendinopathy of the rotator cuff, as well as to treat painful shoulders in patients with rheumatoid arthritis.[57, 58, 59] However, studies are scant, and the results are contradictory regarding the effectiveness of bupivacaine suprascapular nerve blocks in managing FS. Additional studies are needed before conclusions can be drawn.

Stellate block

An uncontrolled study of the combined effect of electropuncture, stellate block, and suprascapular nerve block showed that the combination improved pain control and increased ROM more than electropuncture or nerve block alone.[60]

Contributor Information and Disclosures

André Roy, MD, FRCPC Consulting Staff, Department of Physiatry, Montreal University Hospital Center and Montreal Rehabilitation Institute

André Roy, MD, FRCPC is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.


Thierry HM Adahan, MD LMCC, CCFP, FRCPC, FABPMR, Head, Pain Rehabilitation Center, Haim Sheba Medical Center, Tel Hashomer, Israel

Thierry HM Adahan, MD is a member of the following medical societies: Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Patrick M Foye, MD Director of Coccyx Pain Center, Professor and Interim Chair of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School; Co-Director of Musculoskeletal Fellowship, Co-Director of Back Pain Clinic, University Hospital

Patrick M Foye, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, International Spine Intervention Society, American Association of Neuromuscular and Electrodiagnostic Medicine, Association of Academic Physiatrists

Disclosure: Nothing to disclose.

Chief Editor

Stephen Kishner, MD, MHA Professor of Clinical Medicine, Physical Medicine and Rehabilitation Residency Program Director, Louisiana State University School of Medicine in New Orleans

Stephen Kishner, MD, MHA is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Curtis W Slipman, MD Director, University of Pennsylvania Spine Center; Associate Professor, Department of Physical Medicine and Rehabilitation, University of Pennsylvania Medical Center

Curtis W Slipman, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, Association of Academic Physiatrists, International Association for the Study of Pain, North American Spine Society

Disclosure: Nothing to disclose.


The editors wish to thank Luc Fortin, MD, for his previous contributions to this article.

  1. Staples MP, Forbes A, Green S, et al. Shoulder-specific disability measures showed acceptable construct validity and responsiveness. J Clin Epidemiol. 2009 Aug 13. [Medline].

  2. Wohlgethan JR. Frozen shoulder in hyperthyroidism. Arthritis Rheum. 1987 Aug. 30(8):936-9. [Medline].

  3. Hazleman B. Why is a frozen shoulder frozen?. Br J Rheumatol. 1990 Apr. 29(2):130. [Medline].

  4. Lundberg BJ. The frozen shoulder. Clinical and radiographical observations. The effect of manipulation under general anesthesia. Structure and glycosaminoglycan content of the joint capsule. Local bone metabolism. Acta Orthop Scand Suppl. 1969. 119:1-59. [Medline].

  5. Reeves B. The natural history of the frozen shoulder syndrome. Scand J Rheumatol. 1975. 4(4):193-6. [Medline].

  6. Walmsley S, Rivett DA, Osmotherly PG. Adhesive capsulitis: establishing consensus on clinical identifiers for stage 1 using the DELPHI technique. Phys Ther. 2009 Sep. 89(9):906-17. [Medline].

  7. Ogilvie-Harris DJ, Biggs DJ, Fitsialos DP, et al. The resistant frozen shoulder. Manipulation versus arthroscopic release. Clin Orthop Relat Res. 1995 Oct. 238-48. [Medline].

  8. Binder AI, Bulgen DY, Hazleman BL, Roberts S. Frozen shoulder: a long-term prospective study. Ann Rheum Dis. 1984 Jun. 43(3):361-4. [Medline]. [Full Text].

  9. Rizk TE, Pinals RS. Frozen shoulder. Semin Arthritis Rheum. 1982 May. 11(4):440-52. [Medline].

  10. Sano H, Hatori M, Mineta M, et al. Tumors masked as frozen shoulders: A retrospective analysis. J Shoulder Elbow Surg. 2009 Jun 30. [Medline].

  11. Lequesne M, Dang N, Bensasson M, et al. Increased association of diabetes mellitus with capsulitis of the shoulder and shoulder-hand syndrome. Scand J Rheumatol. 1977. 6(1):53-6. [Medline].

  12. Binder AI, Bulgen DY, Hazleman BL, Tudor J, Wraight P. Frozen shoulder: an arthrographic and radionuclear scan assessment. Ann Rheum Dis. 1984 Jun. 43(3):365-9. [Medline]. [Full Text].

  13. Mao CY, Jaw WC, Cheng HC. Frozen shoulder: correlation between the response to physical therapy and follow-up shoulder arthrography. Arch Phys Med Rehabil. 1997 Aug. 78(8):857-9. [Medline].

  14. Clunie G, Bomanji J, Ell PJ. Technetium-99m-MDP patterns in patients with painful shoulder lesions. J Nucl Med. 1997 Sep. 38(9):1491-5. [Medline]. [Full Text].

  15. Carette S, Moffet H, Tardif J, et al. Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: a placebo-controlled trial. Arthritis Rheum. 2003 Mar. 48(3):829-38. [Medline]. [Full Text].

  16. Green S. Physiotherapy and injection better than injection alone or physiotherapy alone for improving range of motion in adhesive capsulitis. Aust J Physiother. 2003. 49(2):145. [Medline].

  17. Jürgel J, Rannama L, Gapeyeva H, et al. Shoulder function in patients with frozen shoulder before and after 4-week rehabilitation. Medicina (Kaunas). 2005. 41(1):30-8. [Medline]. [Full Text].

  18. Pajareya K, Chadchavalpanichaya N, Painmanakit S, et al. Effectiveness of physical therapy for patients with adhesive capsulitis: a randomized controlled trial. J Med Assoc Thai. 2004 May. 87(5):473-80. [Medline].

  19. Ulusoy H, Sarica N, Arslan S, Olcay C, Erkorkmaz U. The efficacy of supervised physiotherapy for the treatment of adhesive capsulitis. Bratisl Lek Listy. 2011. 112(4):204-7. [Medline].

  20. Griggs SM, Ahn A, Green A. Idiopathic adhesive capsulitis. A prospective functional outcome study of nonoperative treatment. J Bone Joint Surg Am. 2000 Oct. 82-A(10):1398-407. [Medline].

  21. Rizk TE, Christopher RP, Pinals RS, et al. Adhesive capsulitis (frozen shoulder): a new approach to its management. Arch Phys Med Rehabil. 1983 Jan. 64(1):29-33. [Medline].

  22. Rizk TE, Gavant ML, Pinals RS. Treatment of adhesive capsulitis (frozen shoulder) with arthrographic capsular distension and rupture. Arch Phys Med Rehabil. 1994 Jul. 75(7):803-7. [Medline].

  23. Michlovitz SL, Harris BA, Watkins MP. Therapy interventions for improving joint range of motion: A systematic review. J Hand Ther. 2004 Apr-Jun. 17(2):118-31. [Medline].

  24. Russell S, Jariwala A, Conlon R, et al. A blinded, randomized, controlled trial assessing conservative management strategies for frozen shoulder. J Shoulder Elbow Surg. 2014 Apr. 23(4):500-7. [Medline].

  25. Vermeulen HM, Obermann WR, Burger BJ, et al. End-range mobilization techniques in adhesive capsulitis of the shoulder joint: A multiple-subject case report. Phys Ther. 2000 Dec. 80(12):1204-13. [Medline].

  26. Liaw SC. The effect and timing of physiotherapy on change in range of motion and function in frozen shoulder. Physiother Singapore. Sep 2000. 3(3):82-6.

  27. Klç Z, Filiz MB, Çakr T, Toraman NF. Addition of Suprascapular Nerve Block to a Physical Therapy Program Produces an Extra Benefit to Adhesive Capsulitis: A Randomized Controlled Trial. Am J Phys Med Rehabil. 2015 Oct. 94 (10 Suppl 1):912-20. [Medline].

  28. Williams RM, Westmorland MG, Schmuck G, et al. Effectiveness of workplace rehabilitation interventions in the treatment of work-related upper extremity disorders: a systematic review. J Hand Ther. 2004 Apr-Jun. 17(2):267-73. [Medline].

  29. Hazleman BL. The painful stiff shoulder. Rheumatol Phys Med. 1972 Nov. 11(8):413-21. [Medline].

  30. Jacobs LG, Smith MG, Khan SA, et al. Manipulation or intra-articular steroids in the management of adhesive capsulitis of the shoulder? A prospective randomized trial. J Shoulder Elbow Surg. 2009 May-Jun. 18(3):348-53. [Medline].

  31. Favejee MM, Huisstede BM, Koes BW. Frozen shoulder: the effectiveness of conservative and surgical interventions--systematic review. Br J Sports Med. 2011 Jan. 45(1):49-56. [Medline].

  32. Yoon SH, Lee HY, Lee HJ, et al. Optimal dose of intra-articular corticosteroids for adhesive capsulitis: a randomized, triple-blind, placebo-controlled trial. Am J Sports Med. 2013 May. 41(5):1133-9. [Medline].

  33. Lorbach O, Anagnostakos K, Scherf C, et al. Nonoperative management of adhesive capsulitis of the shoulder: oral cortisone application versus intra-articular cortisone injections. J Shoulder Elbow Surg. 2009 Sep 30. [Medline].

  34. Eustace JA, Brophy DP, Gibney RP, Bresnihan B, FitzGerald O. Comparison of the accuracy of steroid placement with clinical outcome in patients with shoulder symptoms. Ann Rheum Dis. 1997 Jan. 56(1):59-63. [Medline]. [Full Text].

  35. Esenyel CZ, Esenyel M, Yesiltepe R, et al. [The correlation between the accuracy of steroid injections and subsequent shoulder pain and function in subacromial impingement syndrome]. Acta Orthop Traumatol Turc. 2003. 37(1):41-5. [Medline].

  36. Naredo E, Cabero F, Beneyto P, et al. A randomized comparative study of short term response to blind injection versus sonographic-guided injection of local corticosteroids in patients with painful shoulder. J Rheumatol. 2004 Feb. 31(2):308-14. [Medline].

  37. Ryans I, Montgomery A, Galway R, et al. A randomized controlled trial of intra-articular triamcinolone and/or physiotherapy in shoulder capsulitis. Rheumatology (Oxford). 2005 Apr. 44(4):529-35. [Medline]. [Full Text].

  38. Vad VB, Sakalkale D, Warren RF. The role of capsular distention in adhesive capsulitis. Arch Phys Med Rehabil. 2003 Sep. 84(9):1290-2. [Medline].

  39. de Jong BA, Dahmen R, Hogeweg JA, et al. Intra-articular triamcinolone acetonide injection in patients with capsulitis of the shoulder: a comparative study of two dose regimens. Clin Rehabil. 1998 Jun. 12(3):211-5. [Medline].

  40. van der Windt DA, Koes BW, Devillé W, Boeke AJ, de Jong BA, Bouter LM. Effectiveness of corticosteroid injections versus physiotherapy for treatment of painful stiff shoulder in primary care: randomised trial. BMJ. 1998 Nov 7. 317(7168):1292-6. [Medline]. [Full Text].

  41. Ranalletta M, Rossi LA, Bongiovanni SL, Tanoira I, Elizondo CM, Maignon GD. Corticosteroid Injections Accelerate Pain Relief and Recovery of Function Compared With Oral NSAIDs in Patients With Adhesive Capsulitis: A Randomized Controlled Trial. Am J Sports Med. 2016 Feb. 44 (2):474-81. [Medline].

  42. Buchbinder R, Green S, Forbes A, Hall S, Lawler G. Arthrographic joint distension with saline and steroid improves function and reduces pain in patients with painful stiff shoulder: results of a randomised, double blind, placebo controlled trial. Ann Rheum Dis. 2004 Mar. 63(3):302-9. [Medline]. [Full Text].

  43. Bunker TD, Anthony PP. The pathology of frozen shoulder. A Dupuytren-like disease. J Bone Joint Surg Br. 1995. 77(5):677-83.

  44. Neer CS 2nd, Satterlee CC, Dalsey RM, et al. The anatomy and potential effects of contracture of the coracohumeral ligament. Clin Orthop. 1992 Jul. (280):182-5. [Medline].

  45. Ozaki J, Nakagawa Y, Sakurai G, et al. Recalcitrant chronic adhesive capsulitis of the shoulder. Role of contracture of the coracohumeral ligament and rotator interval in pathogenesis and treatment. J Bone Joint Surg Am. 1989 Dec. 71(10):1511-5. [Medline].

  46. Andrieu V, Dromer C, Fourcade D, et al. Adhesive capsulitis of the shoulder: therapeutic contribution of subacromial bursography. Rev Rhum Engl Ed. 1998 Dec. 65(12):771-7. [Medline].

  47. Calis M, Demir H, Ulker S, et al. Is intraarticular sodium hyaluronate injection an alternative treatment in patients with adhesive capsulitis?. Rheumatol Int. 2006 Apr. 26(6):536-40. [Medline].

  48. Itokazu M, Matsunaga T. Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder. Clin Ther. 1995 Sep-Oct. 17(5):946-55. [Medline].

  49. Rovetta G, Monteforte P. Intraarticular injection of sodium hyaluronate plus steroid versus steroid in adhesive capsulitis of the shoulder. Int J Tissue React. 1998. 20(4):125-30. [Medline].

  50. Hsieh LF, Hsu WC, Lin YJ, Chang HL, Chen CC, Huang V. Addition of intra-articular hyaluronate injection to physical therapy program produces no extra benefits in patients with adhesive capsulitis of the shoulder: a randomized controlled trial. Arch Phys Med Rehabil. 2012 Jun. 93(6):957-64. [Medline].

  51. Corbeil V, Dussault RG, Leduc BE, et al. [Adhesive capsulitis of the shoulder: a comparative study of arthrography with intra-articular corticotherapy and with or without capsular distension]. Can Assoc Radiol J. 1992 Apr. 43(2):127-30. [Medline].

  52. Gam AN, Schydlowsky P, Rossel I, et al. Treatment of "frozen shoulder" with distension and glucorticoid compared with glucorticoid alone. A randomised controlled trial. Scand J Rheumatol. 1998. 27(6):425-30. [Medline].

  53. Bell S, Coghlan J, Richardson M. Hydrodilatation in the management of shoulder capsulitis. Australas Radiol. 2003 Sep. 47(3):247-51. [Medline].

  54. Piotte F, Gravel D, Moffet H, et al. Effects of repeated distension arthrographies combined with a home exercise program among adults with idiopathic adhesive capsulitis of the shoulder. Am J Phys Med Rehabil. 2004. 83(7):537-46; quiz 547-9.

  55. Jones DS, Chattopadhyay C. Suprascapular nerve block for the treatment of frozen shoulder in primary care: a randomized trial. Br J Gen Pract. 1999 Jan. 49(438):39-41. [Medline]. [Full Text].

  56. Dahan TH, Fortin L, Pelletier M, et al. Double blind randomized clinical trial examining the efficacy of bupivacaine suprascapular nerve blocks in frozen shoulder. J Rheumatol. 2000 Jun. 27(6):1464-9. [Medline].

  57. Emery P, Bowman S, Wedderburn L, Grahame R. Suprascapular nerve block for chronic shoulder pain in rheumatoid arthritis. BMJ. 1989 Oct 28. 299(6707):1079-80. [Medline]. [Full Text].

  58. Gado K, Emery P. Modified suprascapular nerve block with bupivacaine alone effectively controls chronic shoulder pain in patients with rheumatoid arthritis. Ann Rheum Dis. 1993 Mar. 52(3):215-8. [Medline]. [Full Text].

  59. Shanahan EM, Ahern M, Smith M, Wetherall M, Bresnihan B, FitzGerald O. Suprascapular nerve block (using bupivacaine and methylprednisolone acetate) in chronic shoulder pain. Ann Rheum Dis. 2003 May. 62(5):400-6. [Medline]. [Full Text].

  60. Lin ML, Huang CT, Lin JG, et al. [A comparison between the pain relief effect of electroacupuncture, regional never block and electroacupuncture plus regional never block in frozen shoulder]. Acta Anaesthesiol Sin. 1994 Dec. 32(4):237-42. [Medline].

  61. Buchbinder R, Hoving JL, Green S, et al. Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial. Ann Rheum Dis. 2004 Nov. 63(11):1460-9. [Medline].

  62. Vermeulen HM, Rozing PM, Obermann WR, et al. Comparison of high-grade and low-grade mobilization techniques in the management of adhesive capsulitis of the shoulder: randomized controlled trial. Phys Ther. 2006 Mar. 86(3):355-68. [Medline].

  63. Widiastuti-Samekto M, Sianturi GP. Frozen shoulder syndrome: comparison of oral route corticosteroid and intra-articular corticosteroid injection. Med J Malaysia. 2004 Aug. 59(3):312-6. [Medline].

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.